Udp-gluco ceramide glucosyltransferase (UGCG) is the first rate-limiting step in the glucoceramide biosynthetic pathway, promoting glucoceramide production and thereby increasing iNKT cell activity and cytokine production to reduce insulin resistance. The gene discussed is UGCG; the disease is Insulin resistance.